To Compare the Effectiveness of Three Self-care Oral Hygiene Regimens

NCT ID: NCT04804670

Last Updated: 2021-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-19

Study Completion Date

2021-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed to evaluate the clinical changes in gingival health by measuring the reduction of gingival bleeding and inflammation over 4 weeks. Additionally, plaque removal will be evaluated after a single use (part 1) and over 4 weeks (part 2).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data will be analyzed and reported as mean. The target population is approximately 105 healthy adult volunteers. there will be three groups with 35 subjects per group. Subjects will be randomized using a simple random sample. A computer-generated randomization schedule will be prepared by the study statistician. Based on the randomization schedule, subjects will be randomly assigned in a 1:1:1 ratio.

With 35 subjects per group, the study will have 90% power to detect an average reduction in the percent of sites with BOP of 25%.

The primary outcome will be the reduction in the percentage of sites with bleeding on probing (BOP) after 4 weeks.

Reduction in the percentage of sites with BOP after 2 weeks (+/- 2 days). Reduction in the Modified Gingival index after 2 (+/- 2 days) and 4 weeks (+/- 2 days). Reduction in Rustogi Modification of Navy Plaque Index pre \& Post, 2 weeks (+/- 2 days) and 4 weeks (+/- 2 days).

Data will include whole mouth, approximal, marginal, facial, and lingual analysis for all indices. Intraoral examination will be performed and any adverse events will be reported and followed-up.

Subjects will complete a questionnaure at the completion of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sonic-Floss toothbrush and small brush head

sonic toothbrush used for 2 minutes and water flosser used for 1 minute

Group Type EXPERIMENTAL

Power device A

Intervention Type DEVICE

Oral hygiene regimen completed daily

Sonic-Floss toothbrush and full size brush head

sonic toothbrush used for 2 minutes and water flosser used for 1 minute

Group Type EXPERIMENTAL

Power device B

Intervention Type DEVICE

Oral hygiene regimen completed daily

Manual brushing and flossing

American Dental Association standard manual toothbrush used for 2 minutes and dental floss all teeth

Group Type ACTIVE_COMPARATOR

Routine Oral Hygiene

Intervention Type DEVICE

Oral hygiene regimen completed daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Power device A

Oral hygiene regimen completed daily

Intervention Type DEVICE

Power device B

Oral hygiene regimen completed daily

Intervention Type DEVICE

Routine Oral Hygiene

Oral hygiene regimen completed daily

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Provided written informed consent prior to being entered into the study
* Have at least twenty (20) natural teeth (5 evaluable teeth in each quadrant) with scorable facial and lingual surfaces as determined by examiner
* No tobacco use or other substance via the mouth including but not limited to cigarettes, cigars, smokeless tobacco hookah, cannabis, snuff, chew, or vaping electronic cigarettes
* Have a minimum of 50% bleeding on probing sites (6 sites per tooth, total of 120 - 168 total sites)
* Have probing depths \</= 4 mm
* Have a mean baseline gingival index score of \>/= to 1.75 as determined by the Modified Gingival Index.
* Agree not to have a dental prophylaxis or any other elective, non-emergency dental procedures any time during the study
* Agree to abstain from the use of chewing gum, mouth rinses, any toothpaste other than the study toothpaste, tooth whitening products (either professional or at home use) and all other oral hygiene aids other than the study procedures for the duration of the study
* Agree to refrain from all oral hygiene on morning of each evaluation visit
* Agree to comply with the conditions ad schedule of the study

Exclusion Criteria

* Physical limitations or restrictions that might preclude normal tooth brushing.
* Evidence of gross oral pathology, including widespread caries or chronic neglect, extensive restoration, pre-existing gross plaque or soft or hard tissue tumor of the oral cavity.
* Heavy supra- or subgingival calculus that might interfere with evaluations as determined by the examiner.
* Evidence of major oral hard or soft tissue lesions or trauma at the baseline visit as determined by the examiner.
* Conditions requiring antibiotic treatment prior to dental procedures.
* History of uncontrolled diabetes or hepatic or renal disease, or other serious conditions or transmittable disease, (e.g. cardiomyopathy, immunocompromised).
* Subjects with several fully crowned or extensively restored teeth, orthodontic appliances, peri/oral piercings, or removable partial dentures.
* Treatment with antibiotics within 6 months before the baseline examination, or a condition that is likely to require antibiotic treatment over the course of the trial.
* Chronic treatment (2-weeks or more) with any medication known to affect periodontal status (including phenytoin, calcium antagonists, cyclosporine, Coumadin, nonsteroidal anti-inflammatory drugs, and aspirin (325 mg)) within the month before the baseline examination. All other medications for chronic medical conditions must have been initiated at least 3 months before enrollment.
* Have severe periodontal disease or being actively treated for periodontal disease.
* Having history of early-onset periodontitis or acute necrotizing ulcerative gingivitis.
* Concomitant periodontal therapy other than prophylaxis in the last 3 months.
* Professional prophylaxis within 1 month prior to the baseline clinical evaluation.
* Subjects who participated in a gingivitis study in the past month.
* History of significant adverse event following use of oral hygiene products such as toothpastes and mouth rinses.
* Self-reported pregnancy or lactating women or planning to become pregnant during the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Water Pik, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jimmy G Qaqish, BSc

Role: STUDY_DIRECTOR

All Sum Research Center Ltd.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

All Sum Research Center

Mississauga, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

28SFTBF2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.